1. Home
  2. SRPT vs BDJ Comparison

SRPT vs BDJ Comparison

Compare SRPT & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • BDJ
  • Stock Information
  • Founded
  • SRPT 1980
  • BDJ 2005
  • Country
  • SRPT United States
  • BDJ United States
  • Employees
  • SRPT N/A
  • BDJ N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • BDJ Finance Companies
  • Sector
  • SRPT Health Care
  • BDJ Finance
  • Exchange
  • SRPT Nasdaq
  • BDJ Nasdaq
  • Market Cap
  • SRPT 1.9B
  • BDJ 1.6B
  • IPO Year
  • SRPT 1997
  • BDJ N/A
  • Fundamental
  • Price
  • SRPT $17.65
  • BDJ $8.94
  • Analyst Decision
  • SRPT Hold
  • BDJ
  • Analyst Count
  • SRPT 30
  • BDJ 0
  • Target Price
  • SRPT $35.93
  • BDJ N/A
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • BDJ 561.6K
  • Earning Date
  • SRPT 11-03-2025
  • BDJ 01-01-0001
  • Dividend Yield
  • SRPT N/A
  • BDJ 8.85%
  • EPS Growth
  • SRPT N/A
  • BDJ N/A
  • EPS
  • SRPT N/A
  • BDJ N/A
  • Revenue
  • SRPT $2,413,715,000.00
  • BDJ N/A
  • Revenue This Year
  • SRPT $10.20
  • BDJ N/A
  • Revenue Next Year
  • SRPT N/A
  • BDJ N/A
  • P/E Ratio
  • SRPT N/A
  • BDJ N/A
  • Revenue Growth
  • SRPT 47.15
  • BDJ N/A
  • 52 Week Low
  • SRPT $10.42
  • BDJ $6.91
  • 52 Week High
  • SRPT $138.81
  • BDJ $8.66
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 38.30
  • BDJ 41.78
  • Support Level
  • SRPT $15.08
  • BDJ $8.97
  • Resistance Level
  • SRPT $18.80
  • BDJ $9.06
  • Average True Range (ATR)
  • SRPT 1.40
  • BDJ 0.08
  • MACD
  • SRPT -0.84
  • BDJ -0.01
  • Stochastic Oscillator
  • SRPT 24.92
  • BDJ 8.79

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About BDJ Blackrock Enhanced Equity Dividend Trust

BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.

Share on Social Networks: